Africa Mpox Vaccinations: 662,000 Administered
- GENEVA (AP) — The World Health Organization (WHO) released its 51st situation report on the multi-country mpox outbreak, providing updated epidemiological data for Africa as of late April...
- Globally, the WHO has confirmed 137,892 mpox cases and 317 deaths across 132 countries this year.
- In a statement released April 29, 2025, the WHO warned that "wherever mpox outbreaks are not quickly contained and human-to-human transmission is not stopped, they continue to represent...
WHO Reports on Mpox Outbreak: Africa Remains Hotspot
GENEVA (AP) — The World Health Organization (WHO) released its 51st situation report on the multi-country mpox outbreak, providing updated epidemiological data for Africa as of late April 2025.
Globally, the WHO has confirmed 137,892 mpox cases and 317 deaths across 132 countries this year.
Mpox Transmission Concerns
In a statement released April 29, 2025, the WHO warned that “wherever mpox outbreaks are not quickly contained and human-to-human transmission is not stopped, they continue to represent a potential risk of sustained transmission in the community.”
Key Findings in Africa
The report highlights the ongoing prevalence of mpox cases due to clade Ib monkeypox virus (MPXV) in Africa. Eleven countries have reported community transmission of this strain in the past six weeks, with person-to-person transmission occurring through various means.
- Uganda: Currently reporting the highest number of confirmed mpox cases globally, with 200 to 300 new cases reported weekly. only clade Ib MPXV has been detected in the country.
- Democratic Republic of the Congo (DRC): Continues to report the highest cumulative number of confirmed mpox cases in Africa for 2025. However, recent weeks have seen a decrease in reported cases, potentially due to reduced testing and confirmation capacity. clades Ia and Ib MPXV are both circulating in the DRC.
Vaccination Efforts in Africa
The report provides an overview of mpox vaccination efforts in the African Region. To date, more than 662,000 doses of Bavarian nordic’s JYNNEOS (MVA-BN) vaccines have been administered in seven countries.
The DRC has administered 88% of the total doses, but the vaccination strategy is being revised due to limited vaccine supply.
U.S. Vaccine Availability
The U.S.Centers for Disease Control and Prevention (CDC) recommends the JYNNEOS vaccine for specific individuals traveling to areas with mpox outbreaks in 2025. The vaccine is commercially available at clinics and pharmacies throughout the United States.
Mpox outbreak: Your Top questions Answered
What is the latest news on the Mpox outbreak?
The World Health Organization (WHO) released its 51st situation report as of late April 2025, providing updated data on the multi-country mpox outbreak. This report highlights that Africa remains a hotspot for the virus.
How many Mpox cases have been confirmed globally?
Globally, the WHO has confirmed 137,892 mpox cases and 317 deaths across 132 countries this year, as of late April 2025.
What are the WHO’s concerns about Mpox transmission?
In a statement released on April 29, 2025, the WHO warned that mpox outbreaks continue to pose a risk of sustained transmission in the community wherever they are not quickly contained and human-to-human transmission is not stopped.
Where is Mpox most prevalent, according to the WHO report?
The report highlights the ongoing prevalence of mpox cases in Africa. Specifically, the report focuses on the situation in several African countries.
Which African countries are experiencing community transmission?
Eleven countries in Africa have reported community transmission of the clade Ib monkeypox virus (MPXV) within the past six weeks. Person-to-person transmission is occurring through various means within these communities.
Which countries in Africa have the highest number of Mpox cases?
According to the WHO report, two countries stand out:
Uganda: Currently reporting the highest number of confirmed mpox cases globally, with 200 to 300 new cases reported weekly. Only clade Ib MPXV has been detected in uganda.
Democratic Republic of the Congo (DRC): Continues to report the highest cumulative number of confirmed mpox cases in Africa for 2025. However, recent weeks have seen a decrease in reported cases, potentially due to reduced testing and confirmation capacity. Both clades Ia and Ib MPXV are circulating in DRC.
What is the current status of Mpox vaccination efforts in Africa?
The WHO report also provides an overview of Mpox vaccination efforts in the African Region.
Which vaccine is being used and how many doses have been administered?
To date, more than 662,000 doses of Bavarian Nordic’s JYNNEOS (MVA-BN) vaccine have been administered in seven countries.
Which country has administered the most vaccines in Africa, and what challenges exist?
The Democratic Republic of the Congo (DRC) has administered 88% of the total doses. However, the vaccination strategy is being revised due to limited vaccine supply.
Is the Mpox vaccine available in the United States?
Yes, the U.S. Centers for Disease Control and Prevention (CDC) recommends the JYNNEOS vaccine